Jaglix 50 mg filmom obložene tablete
Name | Jaglix 50 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-044641706 |
Active Substance | sitagliptinklorid hidrat |
Composition | jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina |
Pharmaceutical Form | filmom obložena tableta |
Manufacturer | Mylan Hungary Kft, Komárom, Mađarska Medis International A.S., Bolatice, Češka McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin, Dublin, Irska |
Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
Marketing Authorisation Date | 02.11.2022 |
MA Period of Validity | 23.04.2026 |
Classification Number | UP/I-530-09/19-01/283 |
Registration Number | 381-12-01/154-22-14 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | A10BH01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |